What is DTAD, and why was it created?

DTAD, or Dermatology Trainee Advocacy Day, is an initiative designed to empower dermatology trainees—medical students, residents, and faculty—with advocacy tools to influence health policy. It was launched at Harvard in 2020 to address the gap between physicians’ interest in advocacy and their lack of knowledge, time, and exposure to health policy. The day focuses on improving patient access to care and advancing diversity, equity, and inclusion in dermatology.

Why is legislative advocacy important for dermatology trainees?

Legislative advocacy ensures that physicians’ and patients’ voices are heard in policy discussions, which insurers, pharmaceutical companies, and hospital systems often dominate. Advocacy can help pass impactful legislation, influencing the practice of patient-centered medicine and advancing healthcare equity. and inclusion in dermatology.

How does DTAD address barriers to physician advocacy?

DTAD provides training and resources to overcome barriers like lack of knowledge and time. Through workshops, lectures, and interactive sessions, trainees are equipped with the skills to engage effectively in legislative advocacy. The program also fosters a network of mentors and peer support.

What does a typical DTAD agenda look like?

A standard DTAD agenda includes: • Morning: Advocacy 101 (introductory training on legislative processes and advocacy skills) and discussions on 2-3 equity-focused issues. • Afternoon: “Advocacy in Action,” which may involve legislative meetings (virtual or in-person), breakout sessions to draft op-eds or letters, or workshops on advancing local issues.